Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA341520
Max Phase: Preclinical
Molecular Formula: C11H9ClN2O2
Molecular Weight: 236.66
Molecule Type: Small molecule
Associated Items:
ID: ALA341520
Max Phase: Preclinical
Molecular Formula: C11H9ClN2O2
Molecular Weight: 236.66
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(O)c1cc(Cc2ccc(Cl)cc2)[nH]n1
Standard InChI: InChI=1S/C11H9ClN2O2/c12-8-3-1-7(2-4-8)5-9-6-10(11(15)16)14-13-9/h1-4,6H,5H2,(H,13,14)(H,15,16)
Standard InChI Key: YKKXGQMJMUSFFP-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 236.66 | Molecular Weight (Monoisotopic): 236.0353 | AlogP: 2.35 | #Rotatable Bonds: 3 |
Polar Surface Area: 65.98 | Molecular Species: ACID | HBA: 2 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.18 | CX Basic pKa: 0.23 | CX LogP: 2.78 | CX LogD: -0.67 |
Aromatic Rings: 2 | Heavy Atoms: 16 | QED Weighted: 0.86 | Np Likeness Score: -1.07 |
1. van Herk T, Brussee J, van den Nieuwendijk AM, van der Klein PA, IJzerman AP, Stannek C, Burmeister A, Lorenzen A.. (2003) Pyrazole derivatives as partial agonists for the nicotinic acid receptor., 46 (18): [PMID:12930155] [10.1021/jm030888c] |
Source(1):